Gastric Cancer
Evidence-based overview of curcumin in gastric cancer, including H. pylori relevance and inflammation-linked mechanisms
Curcumin's anti-inflammatory and antimicrobial effects make it especially relevant to gastric cancer biology.
Overview
The gastric cancer relevance centres on chronic inflammation, H. pylori, and early carcinogenic signalling.
Key findings
Curcumin shows activity against H. pylori, which is directly relevant to gastric carcinogenesis
Anti-inflammatory signalling may help counter inflammation-driven progression
Review literature supports continued interest, although direct clinical oncology data remains limited
Practical interpretation
This is a biologically coherent area for curcumin, even though the human cancer-treatment evidence is not yet deep.
References
Curcumin and Cancer
https://pubmed.ncbi.nlm.nih.gov/31590362/
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.